Paul Sandle and AstraZeneca

Selected healthcare news for the person - Paul Sandle, and the company - AstraZeneca. We have 47 shared news items for this connection to-date.

Please provide a valid email address.
Paul Sandle Shares Healthcare News With (link):
Healthcare Topics
Companies

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/7/2020 AstraZeneca contacted Gilead over potential megamerger: Bloomberg News Yahoo News 1 / 2 AstraZeneca contacted Gilead over potential megamerger: Bloomberg News FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California By Paul Sandle and Pamela Barbaglia LONDON (Reuters) - Britain's AstraZeneca AZN.L has approached U.S. rival Gilead Sciences GILD.O about a possible merger to form one the world's largest drug companies, Bloomberg News reported on Sunday, citing people familiar with the ...
6/7/2020 AstraZeneca Approached Gilead About Potential Merger: Bloomberg News U.S. News & World Report AstraZeneca Approached Gilead About Potential Merger - Bloomberg News By Reuters , Wire Service Content June 7, 2020 By Reuters , Wire Service Content June 7, 2020, at 4:21 a.m. More FILE PHOTO: Gilead Sciences Inc pharmaceutical company ... April 29, 2020. REUTERS/Mike Blake/File Photo Reuters By Paul Sandle and Pamela Barbaglia LONDON (Reuters) - Britain's AstraZeneca Plc has approached U.S. rival Gilead Sciences Inc about a possible merger that would form one ...
6/7/2020 AstraZeneca approached Gilead about potential merger - Bloomberg News Yahoo News 1 / 2 AstraZeneca approached Gilead about potential merger - Bloomberg News FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York, United States By Paul Sandle and Pamela Barbaglia LONDON (Reuters) - Britain's AstraZeneca Plc has approached U.S. rival Gilead Sciences Inc about a possible merger that would form one the world's largest drug companies, Bloomberg News reported on ...